David Jensen

Writing from the perspective of more than three decades in the news business, Jensen brings a background in business and government to bear on the $3 billion California stem cell agency. Now retired, his career included a 10-year stint as executive business editor of The Sacramento Bee, legislative coverage for United Press International and two years as a press aide to Gov. Jerry Brown during his first term in office. Jensen has covered the stem cell agency since its inception from his sailboat/home located south of the border with visits to California from time to time.

Web Site: http://californiastemcellreport.blogspot.com/


$28 Million California Search for HIV/AIDS Stem Cell Cure Advancing to Clinical Trial

Mar 3, 2015
$28 Million California Search for HIV/AIDS Stem Cell Cure Advancing to Clinical Trial

The California stem cell agency today announced that one of its multimillion dollar efforts to come up with a cure for HIV/AIDS is moving into the first stage of clinical trials involving human beings.


The effort includes the City of Hope in Duarte, Ca., the University of Southern California and Sangamo BioSciences, Inc., of...

California’s Consumer Watchdog Loses U.S. Supreme Court Challege to WARF Stem Cell Patents

Feb 24, 2015

The U.S. Supreme Court yesterday appeared to have put an end to a California’s group nine-year effort to overturn patents on human embryonic stem cells held by the Wisconsin Alumni Research Foundation (WARF).


The court refused to hear the case that was brought by Consumer Watchdog of Santa Monica, Ca., and Jeanne Loring, head...

A Critical Perspective: Klein’s $100 Billion Stem Cell/Genomics Plan ‘Boggles the Mind’

Feb 23, 2015

The San Diego U-T newspaper today reported the first criticism of the $100 billion stem cell/genomics research plan being floated by the former chairman of the California stem cell agency, Bob Klein.


The challenge to the proposal came from John Simpson of Consumer Watchdog of Santa Monica, Ca., in an article by reporter...

$100 Billion Stem/Genomics Plan: Borrowing on an International Scale

Feb 23, 2015
$100 Billion Stem/Genomics Plan: Borrowing on an International Scale

Bob Klein at UC San Diego last week
Bradley Fikes/San Diego U-T photo
More details are emerging on the $100 billion, international stem cell/genomics research proposal being offered up by Bob Klein, the first chairman of California’s stem cell agency.


Prodigious Pricing and Stem Cell Treatments: Implications for the California Stem Cell Agency

Feb 22, 2015
Prodigious Pricing and Stem Cell Treatments: Implications for the California Stem Cell Agency

The most widely read item in the last 10 years on the California Stem Cell Report is one that deals with the cost of a possible stem cell treatment.


Newscom image
The piece contains a $512,000 figure and has chalked up 10,714 page views as of this...

California’s Bob Klein Proposes $100 Billion, International Stem Cell/Genomics Venture

Feb 20, 2015
California’s Bob Klein Proposes $100 Billion, International Stem Cell/Genomics Venture

The man some consider the father of the California stem cell agency has come up with another grand research plan – a $100 billion, 14-nation effort plus California, along with creation of a federal research “trust.”


The proposal comes from Robert Klein, who led the 2004 ballot campaign to create the $3 billion state stem...

The ViaCyte Diabetes Trial: Clarifying a Patient Matter

Feb 19, 2015

The ViaCyte clinical trial is aimed at producing a “virtual” cure for Type 1 diabetes among children, but the first implantation of the device involved an adult man.


That information was reported by the MIT Technology Reviewand raised a question about whether the article was in error or whether something else was involved....

The Sagan Effect and Public Support for Research

Feb 18, 2015

The media chief at the $3 billion California stem cell agency yesterday put together a first-rate piece that invoked Meryl Streep, Carl Sagan and Lindsay Lohan and said that scientists can learn something from them.  


The item by Kevin McCormack, senior director of communications for the stem cell agency, dealt with telling the...

ViaCyte’s hESC Diabetes Effort Examined, Critiqued in MIT Publication

Feb 17, 2015
ViaCyte’s hESC Diabetes Effort Examined, Critiqued in MIT Publication

The ViaCyte device -- photo San Diego U-T
The state of California has invested $55 million in a San Diego firm that last week attracted some East Coast attention for its efforts to develop a “virtual” cure involving Type 1 diabetes.

The firm is Viacyte, which is...

Stem Cell Ethics: An Overview from UC Davis Event

Feb 16, 2015
Stem Cell Ethics: An Overview from UC Davis Event

Alison Sorkin -- Knoepfler photo
California scientist Paul Knoepfler yesterday posted a synopsis of the recent stem cell ethics session at UC Davis that touched on topics ranging from Right to Try laws to hype about hype in stem cell research. 

Writing on his blog, Knoepfler...

Stay connected to Sacramento Connect

Follow Sacramento Connect on Twitter  Find Sacramento Connect on Facebook  Sign up for the Sacramento Connect Newsletter

Advertisement

Categories

  • Hot Topics (2)
  • Shopping (819)
  • Top Stories (3500)

Advertisement